Eterna Therapeutics Inc.
0.44
-0.01 (-2.00%)
At close: Jan 17, 2025, 3:59 PM
0.42
-3.50%
After-hours Jan 17, 2025, 05:55 PM EST
undefined%
Bid 0.42
Market Cap 22.46M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -8.31
PE Ratio (ttm) -0.05
Forward PE n/a
Analyst n/a
Ask 0.44
Volume 2,438,001
Avg. Volume (20D) 10,721,727
Open 0.43
Previous Close 0.45
Day's Range 0.40 - 0.50
52-Week Range 0.22 - 2.63
Beta undefined

About ERNA

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics,...

Industry Biotechnology
Sector Healthcare
IPO Date Aug 29, 1991
Employees 8
Stock Exchange NASDAQ
Ticker Symbol ERNA
3 days ago · Source
+48.22%
Eterna Therapeutics shares are trading higher afte... Unlock content with Pro Subscription